Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Nov 29, 2024
Radioligand therapies are rapidly transforming the neuroendocrine tumor treatment landscape, offering new hope to patients and reshaping the market dynamics. This innovative approach, which combines the precision of targeted therapy with the potency of radiation, is gaining significant traction in the oncology comm...
Read More...
Oct 30, 2024
Neuroendocrine tumors (NET) begin in the neuroendocrine system of the body, developing in cells that interact with neurons and hormone-producing cells. These cells can be found throughout the body, but most often in the abdomen, particularly in the gastrointestinal tract. The tumor can also develop in the lungs, pa...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper